About the Adenocarcinoma Session
Adenocarcinoma is a type of cancer that originates in glandular tissue, which lines organs and forms the secretory portions of glands. It commonly affects organs like the lungs, colon, prostate, pancreas, and breast. Research in adenocarcinoma focuses on understanding genetic mutations and molecular pathways that drive its development and progression. Advances in genomic sequencing have identified key mutations, such as those in the KRAS, EGFR, and BRAF genes, which are pivotal in personalized medicine approaches. Current studies also explore the tumor microenvironment and its role in cancer growth and metastasis. Novel treatments, including targeted therapies and immunotherapies, are being developed and tested in clinical trials, aiming to improve survival rates and quality of life for patients with adenocarcinoma.
Topics Covered in Adenocarcinoma
Glandular Tissue Origin
KRAS & EGFR Mutations
Immunohistochemistry Panels
Carcinoma of Unknown Primary
Mucinous Subtypes
Precision Targeted Therapy
Related Scientific Sessions at CIOC 2027
Why Attend the Adenocarcinoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Adenocarcinoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Adenocarcinoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Adenocarcinoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Adenocarcinoma Conference 2027 — FAQs
What is the Adenocarcinoma track at CIOC 2027?
The Adenocarcinoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Adenocarcinoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Adenocarcinoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Adenocarcinoma are all welcome — whether presenting or attending.
Can I present my research in the Adenocarcinoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Adenocarcinoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Adenocarcinoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.